Laporan Laba Rugi (TTM)
Laporan Laba Rugi Welcure Drugs & Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2024 03-31 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 246 | 334 | 246 | 3,245 |
| Change (%) | 0.00 | 46.05 | -21.41 | -28.91 | 0.00 | 40.94 | -21.43 | 0.00 | 0.00 | -100.12 | -24,550,100.00 | 36.00 | -26.47 | 1,221.65 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 205 | 279 | 205 | 2,892 | |||||||||||
| Change (%) | 36.00 | -26.47 | 1,310.52 | ||||||||||||
| % of Revenue | 83.52 | 83.52 | 83.52 | 89.14 | |||||||||||
| Gross Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 40 | 55 | 40 | 352 |
| Change (%) | 0.00 | 46.05 | -21.41 | -28.91 | 0.00 | 40.94 | -21.43 | 0.00 | 0.00 | -100.12 | -4,046,700.00 | 35.99 | -26.49 | 771.19 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 16.48 | 16.48 | 16.48 | 10.86 |
| SG&A | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 2 | 3 | 4 | 3 |
| Change (%) | 0.00 | -15.73 | 67.22 | 1.17 | 1.15 | -90.10 | 516.93 | 0.00 | -86.53 | 847.28 | 119.47 | 28.08 | 54.76 | -42.70 | |
| % of Revenue | 100.03 | 100.03 | 57.72 | 122.81 | 174.77 | 176.78 | 12.42 | 97.52 | 97.52 | 13.14 | -102,700.00 | 0.92 | 0.86 | 1.82 | 0.08 |
| R&D | |||||||||||||||
| Change (%) | |||||||||||||||
| % of Revenue | |||||||||||||||
| OpEx | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 232 | 310 | 218 | 2,902 |
| Change (%) | -7.64 | -6.08 | 65.85 | -3.00 | 1.51 | -36.34 | 12.20 | -7.88 | -70.98 | 615.79 | 13,147.43 | 33.96 | -29.82 | 1,233.05 | |
| % of Revenue | 98.90 | 91.35 | 58.74 | 123.95 | 169.13 | 171.68 | 77.54 | 110.73 | 102.00 | 29.60 | -174,800.00 | 94.32 | 92.91 | 88.68 | 89.44 |
| Operating Income | 0 | 0 | 1 | -0 | -1 | -1 | 0 | -0 | -0 | 1 | 1 | 14 | 24 | 28 | 343 |
| Change (%) | 689.10 | 596.31 | -145.62 | 105.18 | 3.69 | -144.16 | -137.54 | -81.33 | -3,614.63 | 48.25 | 1,518.47 | 69.86 | 17.45 | 1,132.36 | |
| % of Revenue | 1.10 | 8.65 | 41.26 | -23.95 | -69.13 | -71.68 | 22.46 | -10.73 | -2.00 | 70.40 | -86,100.00 | 5.68 | 7.09 | 11.32 | 10.56 |
| Interest Expense | |||||||||||||||
| Change (%) | |||||||||||||||
| % of Revenue | |||||||||||||||
| Net Income | 0 | 0 | 1 | 0 | -0 | -0 | 0 | -0 | -0 | 1 | -2 | 14 | 19 | 22 | 258 |
| Change (%) | 369.28 | 528.93 | -53.94 | -106.30 | 118.75 | -773.69 | -137.83 | -80.71 | -3,481.14 | -400.45 | -928.32 | 30.44 | 14.90 | 1,089.54 | |
| % of Revenue | 2.05 | 9.60 | 41.36 | 24.24 | -2.15 | -4.70 | 22.46 | -10.81 | -2.09 | 70.52 | 174,800.00 | 5.90 | 5.66 | 8.84 | 7.96 |
Source: Capital IQ
